Tirzepatide Side Effects: Common, Serious and Long Term

Tirzepatide is a prescription medicine used for type 2 diabetes and chronic weight management. It is marketed under brand names such as Mounjaro, Zepbound, and Yurpeak. It works by activating two key hormone receptors in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones help regulate appetite, improve blood sugar control, slow gastric emptying, and support weight loss. By acting on both pathways, tirzepatide can produce greater effects on weight and glucose control compared with medicines that target only a single pathway.

While tirzepatide can be highly effective, it is important to understand its possible side effects before starting treatment. This article explains the side effects you may experience with tirzepatide, highlights symptoms that should not be ignored, and outlines what is currently known about its long-term safety.

If you have been prescribed tirzepatide or are considering it, questions about side effects are often among the first concerns. Tirzepatide works by slowing how quickly food leaves the stomach and activating appetite-regulating hormones, helping people feel full for longer while also contributing to many of the early gastrointestinal effects seen during treatment. It is the active ingredient in medicines such as Mounjaro and Yurpeak.

For most people, these side effects are manageable and improve over time. However, in some cases, they may persist or become severe enough to require dose adjustment or stopping treatment. Understanding what to expect before starting tirzepatide can make the treatment experience easier and help you manage side effects more effectively.

The most common side effects with tirzepatide are usually mild to moderate and tend to improve within the first few weeks of treatment. They may also reappear briefly after dose increases before settling again. They may include:

• Nausea and vomiting.
• Diarrhoea.
• Reduced appetite.
• Constipation
• Indigestion and bloating
• Stomach pain
• Sulphur burps
• Injection site reactions
• Cutaneous hypersensitivity reactions
• Fatigue

These are less common but need prompt medical attention. Contact your doctor or seek emergency care if you develop any of the following.

Pancreatitis

Pancreatitis is inflammation of the pancreas. It occurs in less than 1% of patients.

Symptoms may include:

• Severe, persistent pain in the upper abdomen
• Pain that spreads to the back
• Nausea and vomiting alongside the pain
• Fever

Gallbladder Disease

Gallbladder disease, including gallstones and gallbladder inflammation (cholecystitis). Rapid weight loss alters bile composition and reduces gallbladder motility, both of which increase the risk of gallstone formation.

Symptoms may include:

• Sudden pain in the upper right abdomen, often after a fatty meal
• Clay-coloured stools
• Fever
• Yellowing of the skin or whites of the eyes (jaundice)

Kidney Problems

Tirzepatide does not directly damage the kidneys. However, significant vomiting or diarrhoea can cause dehydration, and dehydration can lead to acute kidney injury (a sudden reduction in kidney function).

Symptoms to watch for:

• Reduced urine output or very dark urine
• Swelling in the legs or feet
• Unusual tiredness or confusion

Hypoglycaemia (Low Blood Sugar)

Tirzepatide on its own has a low risk of causing hypoglycaemia (low blood sugar). However, the risk increases when it is used together with other diabetes medicines, especially insulin or sulfonylureas.

Symptoms to watch for:

• Shakiness and sweating
• Rapid heartbeat
• Dizziness or confusion
• Blurred vision

Diabetic Retinopathy

In people with type 2 diabetes, tirzepatide may sometimes make diabetic retinopathy (eye damage from diabetes) worse for a short time. This usually happens when blood sugar improves very quickly after starting the medicine or raising the dose.

Symptoms may include:

• Blurred vision
• Sudden changes in vision
• Floaters (dark spots or threads moving in your vision)
• Vision loss in one or both eyes

Allergic Reactions

Some people may develop allergic reactions while using tirzepatide. These can range from mild skin irritation to more serious symptoms. Stop the injection and seek emergency medical help right away if you notice:

• Hives or widespread rash
• Swelling of the face, lips, tongue, or throat
• Difficulty breathing or swallowing
• Severe dizziness

Increased Heart Rate

Some people may experience a rise in resting heart rate while using tirzepatide. For most, this increase is small and not noticeable, but it can be more significant in certain cases. People with existing heart conditions should be monitored closely. Seek medical advice right away if you notice:

• Palpitations or a racing heartbeat
• Chest pain
• Dizziness or fainting

Tirzepatide carries an FDA boxed warning, the most serious level of safety warning applied to prescription medicines. The warning relates to a possible risk of thyroid C-cell tumours, including medullary thyroid carcinoma (MTC), a type of thyroid cancer that arises from cells in the thyroid gland. Animal studies showed an increased rate of these tumours in rodents given tirzepatide. Whether this risk occurs in people taking tirzepatide at clinical doses is not yet confirmed.

Long-term research on tirzepatide is still ongoing. Current clinical studies and real-world reports suggest a few important areas to be aware of during extended use.

• Weight regain after stopping (regaining lost weight once the medicine is discontinued)
• Gallbladder disease (gallstones or inflammation of the gallbladder, a small organ that helps digest fat)
• Diabetic retinopathy (eye damage related to diabetes that can affect vision)
• Gastroparesis (very slow stomach emptying, where food stays in the stomach longer than normal)
• Risk before surgery (slower stomach emptying may increase the risk of food remaining in the stomach during anesthesia, so doctors may advise stopping the medicine before surgery)
• Hair loss (temporary shedding of hair, often linked to rapid weight loss or stress on the body)
• Facial and body fat changes (loss of fat leading to a slimmer or “hollowed” facial appearance in some people)

• Severe or persistent abdominal pain, especially when radiating to the back
• Repeated vomiting for more than 24 to 48 hours
• Signs of dehydration, such as dark urine, dizziness, or significantly reduced urination
• Any new or sudden changes in vision
• A lump in the neck, hoarseness, or difficulty swallowing
• Signs of an allergic reaction, including hives, facial swelling, or breathing difficulty
• Blood sugar levels repeatedly falling below 70 mg/dL

• https://www.drugs.com/sfx/mounjaro-side-effects.html
• https://www.medicalnewstoday.com/articles/drugs-mounjaro-side-effects
• https://www.diabetes.org.uk/about-diabetes/looking-after-diabetes/treatments/tablets-and-medication/glp-1/mounjaro
• https://pi.lilly.com/us/mounjaro-uspi.pdf
• https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/
• https://doi.org/10.1001/jama.2023.24945
• https://pmc.ncbi.nlm.nih.gov/articles/PMC12800350/
• https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/
• https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro